These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33656069)

  • 1. Sildenafil as an Eligible Heart Transplantation Therapy for Advanced Heart Failure Associated with Fixed Pulmonary Hypertension.
    Schwartzmann P
    Arq Bras Cardiol; 2021 Feb; 116(2):227-228. PubMed ID: 33656069
    [No Abstract]   [Full Text] [Related]  

  • 2. Dramatic improvement of clinical and hemodynamic parameters of a heart transplant candidate with sildenafil treatment.
    Gerede DM; Sayın T; Vurgun VK; Akbulut IM; Erol C
    Int J Cardiol; 2015 Apr; 185():148-9. PubMed ID: 25795206
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid improvement of pulmonary hemodynamics following combined tadalafil and inotropic treatment in a patient with pulmonary hypertension secondary to left ventricular dysfunction.
    Güvenç TS; Ekmekçi A; Sargın M; Orhan G; Eren M
    Int J Cardiol; 2016 Jan; 203():212-3. PubMed ID: 26512839
    [No Abstract]   [Full Text] [Related]  

  • 4. Sildenafil in heart transplant candidates with pulmonary hypertension.
    de Groote P; El Asri C; Fertin M; Goéminne C; Vincentelli A; Robin E; Duva-Pentiah A; Lamblin N
    Arch Cardiovasc Dis; 2015; 108(6-7):375-84. PubMed ID: 25921840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taking aim at pulmonary hypertension in heart failure with preserved ejection fraction.
    Borlaug BA
    Eur Heart J; 2015 Oct; 36(38):2574-5. PubMed ID: 26188000
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary vascular resistance as a potential marker of reactive pulmonary hypertension reduction following sildenafil therapy in patients disqualified from orthotopic heart transplantation.
    Duszańska A; Wasilewski J; Gierlotka M; Zakliczyński M
    Adv Med Sci; 2020 Sep; 65(2):298-303. PubMed ID: 32454454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial.
    Hoendermis ES; Liu LC; Hummel YM; van der Meer P; de Boer RA; Berger RM; van Veldhuisen DJ; Voors AA
    Eur Heart J; 2015 Oct; 36(38):2565-73. PubMed ID: 26188003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sildenafil on cardiac structure and function, cardiopulmonary exercise testing and health-related quality of life measures in heart failure patients with preserved ejection fraction and pulmonary hypertension.
    Liu LC; Hummel YM; van der Meer P; Berger RM; Damman K; van Veldhuisen DJ; Voors AA; Hoendermis ES
    Eur J Heart Fail; 2017 Jan; 19(1):116-125. PubMed ID: 27873388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of sildenafil for pulmonary hypertension in neonates.
    Márquez-González H; Ríos DI; Jean Tron MG; Barajas-Nava LA
    Bol Med Hosp Infant Mex; 2020; 77(4):202-206. PubMed ID: 32713951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcoidosis-associated pulmonary hypertension treated with sildenafil - a case report.
    Kacprzak A; Szturmowicz M; Burakowska B; Franczuk M; Kober J; Kurzyna M; Wilk M; Szmit S; Torbicki A; Kuś J
    Adv Respir Med; 2017; 85(5):258-263. PubMed ID: 29083021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic sildenafil use on pulmonary hemodynamics and clinical outcomes in heart transplantation.
    Pons J; Leblanc MH; Bernier M; Cantin B; Bourgault C; Bergeron S; Proulx G; Morin J; Nalli C; O'Connor K; Chateauvert N; Sénéchal M
    J Heart Lung Transplant; 2012 Dec; 31(12):1281-7. PubMed ID: 23127754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Clinical and Hemodynamic Outcomes after Heart Transplantation in Patients Pre-Treated with Sildenafil.
    Mendes SL; Moreira N; Batista M; Ferreira AR; Marinho AV; Prieto D; Baptista R; Costa S; Franco F; Pego M; Antunes MJ
    Arq Bras Cardiol; 2021 Feb; 116(2):219-226. PubMed ID: 33656068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary hypertension associated with the human immunodeficiency virus in children: treatment with sildenafil. A case report].
    Stepffer C; Gaynor E; López M; González NE; Arri M; De Dios AM
    Arch Argent Pediatr; 2018 Jun; 116(3):e437-e441. PubMed ID: 29756719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide.
    Lepore JJ; Maroo A; Bigatello LM; Dec GW; Zapol WM; Bloch KD; Semigran MJ
    Chest; 2005 May; 127(5):1647-53. PubMed ID: 15888841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial.
    Bermejo J; Yotti R; García-Orta R; Sánchez-Fernández PL; Castaño M; Segovia-Cubero J; Escribano-Subías P; San Román JA; Borrás X; Alonso-Gómez A; Botas J; Crespo-Leiro MG; Velasco S; Bayés-Genís A; López A; Muñoz-Aguilera R; de Teresa E; González-Juanatey JR; Evangelista A; Mombiela T; González-Mansilla A; Elízaga J; Martín-Moreiras J; González-Santos JM; Moreno-Escobar E; Fernández-Avilés F;
    Eur Heart J; 2018 Apr; 39(15):1255-1264. PubMed ID: 29281101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of sublingual sildenafil on pulmonary hypertension in patients with heart failure.
    Freitas AF; Bacal F; Oliveira Jde L; Santos RH; Moreira LF; Silva CP; Mangini S; Carneiro RM; Fiorelli AI; Bocchi EA
    Arq Bras Cardiol; 2009 Feb; 92(2):116-26. PubMed ID: 19360244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil and assessment of pulmonary arterial reactivity in heart failure.
    Alaeddini J; Uber P; Park MH; Scott RL; Mehra MR
    Congest Heart Fail; 2003; 9(3):176-8. PubMed ID: 12826777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design.
    Behr J; Nathan SD; Harari S; Wuyts W; Kirchgaessler KU; Bengus M; Gilberg F; Wells AU
    Respir Med; 2018 May; 138():13-20. PubMed ID: 29724385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of resolution of pulmonary hypertension, long-term allograft right ventricular function, and exercise capacity in high-risk heart transplant recipients listed under oral sildenafil.
    De Santo LS; Buonocore M; Agrusta F; Bancone C; Galdieri N; Romano G; Maiello C; Amarelli C
    Clin Transplant; 2014 Jul; 28(7):837-43. PubMed ID: 24828060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of sildenafil for pulmonary hypertension due to left heart disease with HFrEF.
    Jiang R; Wang L; Zhu CT; Yuan P; Pudasaini B; Zhao QH; Gong SG; He J; Liu JM; Hu QH
    Hypertens Res; 2015 Dec; 38(12):829-39. PubMed ID: 26202179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.